| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | — | -27.1% |
| R&D Expense | $350K | — | -4.8% |
| SG&A Expense | $3.2M | — | +32.2% |
| Operating Income | -$3.6M | — | -37.7% |
| Pre-tax Income | -$3.6M | — | -36.9% |
| Income Tax | $9K | — | +0.0% |
| Net Income | -$3.6M | — | -36.5% |
| EPS (Basic) | -$0.81 | — | -406.3% |
| EPS (Diluted) | -$0.81 | — | -406.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.1M | -52.0% | +596.7% |
| Accounts Receivable | $685K | +26.4% | -28.9% |
| Inventory | $78K | +45.5% | +100.8% |
| Current Assets | $4.3M | -42.6% | +132.9% |
| Total Assets | $7.9M | -27.5% | +43.2% |
| Current Liabilities | $3.2M | +9.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.2M | — | -96.6% |
| Capital Expenditures | $6K | — | -88.8% |
| Investing Cash Flow | -$6K | — | +88.8% |
| Financing Cash Flow | -$119K | — | -111.5% |
| Free Cash Flow | -$3.2M | — | -91.0% |
| -6.7% |
| Total Liabilities | $4.3M | +16.3% | +4.3% |
| Stockholders' Equity | $3.7M | -49.7% | +154.4% |